TY  - GEN
AU  - Olson,Matthew R
AU  - Varga,Steven M
TI  - Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease
SN  - 1550-6606
PY  - 2009///0421
KW  - Adjuvants, Immunologic
KW  - administration & dosage
KW  - Animals
KW  - Autoimmune Diseases
KW  - genetics
KW  - CD4-Positive T-Lymphocytes
KW  - immunology
KW  - CD8-Positive T-Lymphocytes
KW  - Cell Differentiation
KW  - Epitopes, T-Lymphocyte
KW  - Fas Ligand Protein
KW  - biosynthesis
KW  - Humans
KW  - Immunization, Secondary
KW  - Immunologic Memory
KW  - Lymphatic Diseases
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Mutant Strains
KW  - Pulmonary Eosinophilia
KW  - Respiratory Syncytial Virus Vaccines
KW  - Respiratory Syncytial Viruses
KW  - Viral Envelope Proteins
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.4049/jimmunol.0803585
ER  -